These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16700419)

  • 1. [Avascular jaw osteonecrosis associated with bisphophonate therapy].
    Broglia C; Merlati G; Valentino F; Benatti C; Gobbi P; Ascari E
    Recenti Prog Med; 2006 Mar; 97(3):140-4. PubMed ID: 16700419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteonecrosis of the jaw in the course of multiple myeloma treatment and bisphosphonate administration].
    Adam Z; Kozumpliková M; Pour L; Machálka M
    Vnitr Lek; 2006 Feb; 52(2):176-80. PubMed ID: 16623282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osteonecrosis of the jaw associated with the use of bisphosphonates in multiple myeloma: report of four cases and literature review].
    Li LH; Wu XB; Chen WM; Chen JX; Wu Y; Chen SL
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2986-7. PubMed ID: 19080077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
    Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
    Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws.
    Allegra A; Alonci A; Penna G; Granata A; Nastro Siniscalchi E; Oteri G; Loddo S; Teti D; Cicciù D; De Ponte FS; Musolino C
    Acta Haematol; 2010; 124(2):79-85. PubMed ID: 20639624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma.
    Diego R; D'Orto O; Pagani D; Agazzi A; Marzano U; Derada Troletti G; Fontanella W; Pignataro L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e1-5. PubMed ID: 17197204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration.
    Oteri G; Allegra A; Bellomo G; Alonci A; Nastro E; Penna G; Catalfamo L; Cicciù D; De Ponte FS; Musolino C
    Cytokine; 2008 Aug; 43(2):103-4. PubMed ID: 18585926
    [No Abstract]   [Full Text] [Related]  

  • 9. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
    Gutta R; Louis PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical guidelines for prevention of osteonecrosis of the jaws in patients in treatment with bisphosphonates: literature review and report of three cases.
    Sarzi Amadè D; Tallarico M; Loreti MC; Montecchi PP; Niccoli A
    Minerva Stomatol; 2008 Sep; 57(9):429-46. PubMed ID: 18923378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
    Mortensen M; Lawson W; Montazem A
    Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates and osteonecrosis of the jaws.
    Mariotti A
    J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaws in patients treated with bisphosphonates. Review of the literature and the Milan experience.
    Oltolina A; Achilli A; Lodi G; Demarosi F; Sardella A
    Minerva Stomatol; 2005; 54(7-8):441-8. PubMed ID: 16211002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of jaws after bisphosphonates: an internet resource on the web for dentist.
    Hon NC
    Singapore Dent J; 2007 Dec; 29(1):19-21. PubMed ID: 18472526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
    Kraj M; Pogłód R; Maj S; Owczarska K
    Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
    [No Abstract]   [Full Text] [Related]  

  • 18. Bisphosphonate osteonecrosis of the jaws; an increasing problem for the dental practitioner.
    McLeod NM; Davies BJ; Brennan PA
    Br Dent J; 2007 Dec; 203(11):641-4. PubMed ID: 18065983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jaw osteonecrosis related to bisphosphonate treatment of bone metastasis.
    Raffaelli L; Scaramuzzo L; Rossi Iommetti P; Graci C; Maccauro G; Manicone PF
    J Biol Regul Homeost Agents; 2010; 24(2):115-21. PubMed ID: 20487624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates and jaw osteonecrosis: the UAMS experience.
    Clarke BM; Boyette J; Vural E; Suen JY; Anaissie EJ; Stack BC
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):396-400. PubMed ID: 17321866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.